Omega -3 fatty acids
Dietary SupplementEach subject assigned to active treatment group will receive 4 g/day capsule of omega-3 fatty acids.
NCT Number: NCT02103517
The purpose of this study is to determine whether omega-3 fatty acids supplementation are effective in the improvement of suboptimal health status and cardiovascular risk.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Phase 3
Chinese PLA General Hospital, Beijing, Beijing Municipality, China
The Suboptimal health status questionnaire (SHSQ-25) is used to evaluate the suboptimal health status. The SHSQ-25 includes 25 questions. The score of the SHSQ-25 is from 0 to 100. Suboptimal health status is defined as the SHSQ-25 score above than 35. The higher scores of the SHSQ-25 one gets, the more severity of suboptimal health status he/she has. All participants are asked to fill in the SHSQ-25 before and after the intervention. If the score decreases after the intervention, it means that the suboptimal health status has been improved.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each subject assigned to active treatment group will receive 4 g/day capsule of omega-3 fatty acids.
Each subject assigned to the control group will receive 4 g/day capsule of corn oil.
Time frame: three months
The improvement of suboptimal health status is evaluated by the change of the SHSQ-25 scores after intervention.
Time frame: three months
To investigate the changes of traditional cardiovascular risk factors such as blood pressure, lipids, fasting plasma glucose, and body mass index with three months supplementation of omega-3 fatty acids. Abnormal cardiovascular risk factors are defined according to the Adult Treatment Panel III criteria for metabolic syndromes and the recommendation by the Working Group on Obesity in China. The number of abnormal cardiovascular risk factors for each participant is recorded before and after intervention. If the number decreases after intervention, it means that the traditional cardiovascular risk factors have been improved.
Chinese PLA General Hospital
Other
Risk and Prevention Study: Optimisation of the Preventive Strategies and Evaluation of the Efficacy of n-3 Fatty Acids in Subjects at High Cardiovascular Risk and Suboptimal Health Status
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02441010
Metabolic Abnormality, Suboptimal Health Status
Beijing, Beijing Municipality, China
View Trial DetailsNCT07391462
Behavior, Sedentary
Beynost, France
View Trial Details